{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:16:00Z","timestamp":1788196560934,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,12]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Endothelial dysfunction plays a central role in the pathophysiology of cardiovascular, renal, and metabolic diseases. The Endothelial Activation Stress Index (EASIX) has emerged as a promising prognostic marker in endothelial-related disorders. This study aimed to evaluate the association between EASIX and the risks of all-cause and cardiovascular mortality in individuals with cardio-renal-metabolic (CKM) syndrome stages 0 to 3. Data were obtained from the National Health and Nutrition Examination Survey 2005 to 2010 and 2015 to 2018 cycles. A total of 7046 participants with CKM stages 0 to 3 were included. EASIX was calculated as lactate dehydrogenase\u2005\u00d7\u2005creatinine\/platelet count. The primary outcome was cardiovascular mortality, and the secondary outcome was all-cause mortality, ascertained through linkage to the National Death Index. The optimal cutoff value of EASIX was determined using maximally selected rank statistics. Associations were assessed using survey-weighted Cox proportional hazards models, restricted cubic splines, and subgroup analyses. Predictive performance was evaluated using time-dependent receiver operating characteristic curves. Mediation analysis and competing risk models were also performed. Higher EASIX (\u22650.64) was significantly associated with increased risks of cardiovascular mortality (adjusted hazard ratio\u2005=\u20051.65, 95% confidence interval\u2005=\u20051.11\u20132.46) and all-cause mortality (adjusted hazard ratio\u2005=\u20051.45, 95% confidence interval\u2005=\u20051.16\u20131.81). Restricted cubic spline analysis revealed a significant nonlinear relationship between EASIX and mortality (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). Kaplan\u2013Meier curves showed lower survival probabilities in the high-EASIX group (log-rank\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001). The association remained consistent across subgroups. EASIX demonstrated good predictive performance for 1-, 3-, and 5-year mortality. Mediation analysis indicated that chronic kidney disease accounted for approximately 30% to 35% of the observed associations. Competing risk analysis confirmed the independent association between EASIX and cardiovascular mortality. EASIX is a simple and robust predictor of all-cause and cardiovascular mortality in patients with CKM stages 0 to 3, and may facilitate early risk stratification and personalized management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049239","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:00:20Z","timestamp":1781600420000},"page":"e49239","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Endothelial Activation Stress Index and risk of all-cause and cardiovascular mortality in early-stage cardio-renal-metabolic syndrome: A nationwide retrospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8915-7822","authenticated-orcid":false,"given":"Rui","family":"Han","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Diseases, The First Hospital of Jilin University, Changchun, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, The Second Affiliated Hospital of Harbin Medical University, Harbin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2033-2099","authenticated-orcid":false,"given":"Shanshan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, The First Hospital of Jilin University, Changchun, Jilin Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260831","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.3390\/jcm14082833","article-title":"Cardiovascular-kidney-metabolic syndrome: a new paradigm in clinical medicine or going back to basics?","volume":"14","author":"Mutruc","year":"2025","journal-title":"J Clin Med"},{"key":"R2-20260831","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1681\/ASN.0000000637","article-title":"Cumulative incidence of mortality associated with cardiovascular-kidney-metabolic (CKM) syndrome.","volume":"36","author":"Claudel","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"R3-20260831","doi-asserted-by":"crossref","first-page":"e1004629","DOI":"10.1371\/journal.pmed.1004629","article-title":"Cardiovascular-kidney-metabolic syndrome and all-cause and cardiovascular mortality: a retrospective cohort study.","volume":"22","author":"Tsai","year":"2025","journal-title":"PLoS Med"},{"key":"R4-20260831","doi-asserted-by":"crossref","first-page":"118585","DOI":"10.1016\/j.atherosclerosis.2024.118585","article-title":"Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality.","volume":"397","author":"Li","year":"2024","journal-title":"Atherosclerosis"},{"key":"R5-20260831","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12933-025-02842-1","article-title":"Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: a prospective cohort study of 282,920 participants in the UK Biobank.","volume":"24","author":"Liu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R6-20260831","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12933-025-02589-9","article-title":"Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.","volume":"24","author":"Zheng","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R7-20260831","doi-asserted-by":"crossref","first-page":"1612121","DOI":"10.3389\/fcvm.2025.1612121","article-title":"The role of triglyceride-glucose index in the progression of cardiovascular-kidney-metabolic syndrome: findings from the China Health and Retirement Longitudinal Study.","volume":"12","author":"Zhou","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"R8-20260831","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/CIRCRESAHA.123.324001","article-title":"Cardiovascular consequences of uremic metabolites: an overview of the involved signaling pathways.","volume":"134","author":"Curaj","year":"2024","journal-title":"Circ Res"},{"key":"R9-20260831","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.3390\/ijms25052973","article-title":"New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications.","volume":"25","author":"Gallo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R10-20260831","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s12015-025-11000-9","article-title":"Association of EASIX score with non-relapse mortality and overall survival in pediatric acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.","volume":"22","author":"Kasaeian","year":"2026","journal-title":"Stem Cell Rev Rep"},{"key":"R11-20260831","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.3390\/jcm14082857","article-title":"Endothelial activation and stress index-a novel and simple prognostic tool in coronary artery bypass grafting.","volume":"14","author":"Krombholz-Reindl","year":"2025","journal-title":"J Clin Med"},{"key":"R12-20260831","doi-asserted-by":"crossref","first-page":"133566","DOI":"10.1016\/j.ijcard.2025.133566","article-title":"Endothelial dysfunction assessed by the endothelial activation and stress index (EASIX) predicts risk of mortality in chronic heart failure patients.","volume":"438","author":"Estler","year":"2025","journal-title":"Int J Cardiol"},{"key":"R13-20260831","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R14-20260831","doi-asserted-by":"crossref","first-page":"e036669","DOI":"10.1161\/JAHA.124.036669","article-title":"Predictive value of life\u2019s crucial 9 for cardiovascular and all-cause mortality: a prospective cohort study from the NHANES 2007 to 2018.","volume":"13","author":"Ge","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"R15-20260831","doi-asserted-by":"crossref","first-page":"1346669","DOI":"10.3389\/fendo.2024.1346669","article-title":"Association of metabolic syndrome and sarcopenia with all-cause and cardiovascular mortality: a prospective cohort study based on the NHANES.","volume":"15","author":"Huang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R16-20260831","doi-asserted-by":"crossref","first-page":"e47988","DOI":"10.1097\/MD.0000000000047988","article-title":"Association of the Endothelial Activation and Stress Index (EASIX) with short-term mortality in critically ill patients with congestive heart failure: A retrospective cohort study from the MIMIC database.","volume":"105","author":"Dong","year":"2026","journal-title":"Medicine (Baltimore)"},{"key":"R17-20260831","doi-asserted-by":"crossref","first-page":"993930","DOI":"10.3389\/fcvm.2022.993930","article-title":"Association of the composite dietary antioxidant index with all-cause and cardiovascular mortality: a prospective cohort study.","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R18-20260831","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3390\/jcm9082359","article-title":"Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update.","volume":"9","author":"Roumeliotis","year":"2020","journal-title":"J Clin Med"},{"key":"R19-20260831","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/CIRCRESAHA.123.321752","article-title":"Endothelial cell dysfunction and increased cardiovascular risk in patients with chronic kidney disease.","volume":"132","author":"Baaten","year":"2023","journal-title":"Circ Res"},{"key":"R20-20260831","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/ijms23010531","article-title":"Impact of uremic toxins on endothelial dysfunction in chronic kidney disease: a systematic review.","volume":"23","author":"Harlacher","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R21-20260831","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.3390\/ijms26083732","article-title":"Gene expression profile of cultured human coronary arterial endothelial cells exposed to serum from chronic kidney disease patients: role of MAPK signaling pathway.","volume":"26","author":"Rangel-L\u00f3pez","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R22-20260831","doi-asserted-by":"crossref","first-page":"e2402066","DOI":"10.1002\/advs.202402066","article-title":"Uremic toxin receptor AhR facilitates renal senescence and fibrosis via suppressing mitochondrial biogenesis.","volume":"11","author":"Xie","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"R23-20260831","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment.","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R24-20260831","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5543\/tkda.2025.54829","article-title":"Assessment of the efficacy of the hemoglobin, albumin, lymphocyte, and platelet score in predicting recurrence of atrial fibrillation following cryo-balloon ablation.","volume":"53","author":"Kalendero\u011flu","year":"2025","journal-title":"Turk Kardiyol Dern Ars"},{"key":"R25-20260831","first-page":"112","article-title":"Clinical implications of pan-immune-inflammatory values in patients with hypertrophic cardiomyopathy.","volume":"53","author":"Kalendero\u011flu","year":"2025","journal-title":"Turk Kardiyol Dern Ars"},{"key":"R26-20260831","first-page":"45","article-title":"Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction.","volume":"49","author":"Kalendero\u011flu","year":"2026","journal-title":"Pacing Clin Electrophysiol"},{"key":"R27-20260831","first-page":"312","article-title":"Evaluation of N\/LP ratio as a predictor of disease progression and mortality in COVID-19 patients admitted to the intensive care unit.","volume":"37","author":"Kalendero\u011flu","year":"2022","journal-title":"J Intensive Care Med"},{"key":"R28-20260831","first-page":"6","article-title":"A new risk prediction model for the assessment of myocardial injury in elderly patients undergoing non-elective surgery.","volume":"12","author":"Kalendero\u011flu","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"key":"R29-20260831","first-page":"156","article-title":"The predictive value of age, creatinine, ejection fraction score for in-hospital mortality in patients with cardiogenic shock.","volume":"38","author":"Kalendero\u011flu","year":"2020","journal-title":"Am J Emerg Med"},{"key":"R30-20260831","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","article-title":"Endothelium structure and function in kidney health and disease.","volume":"15","author":"Jourde-Chiche","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"R31-20260831","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.3390\/jcm14134567","article-title":"Cardiovascular risk and its presentation in chronic kidney disease.","volume":"14","author":"Schunk","year":"2025","journal-title":"J Clin Med"},{"key":"R32-20260831","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.3390\/ijms25137274","article-title":"Endothelial protection by sodium-glucose cotransporter 2 inhibitors: a literature review of in vitro and in vivo studies.","volume":"25","author":"Mylonas","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R33-20260831","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.3390\/ijms23073651","article-title":"An overview of the cardiorenal protective mechanisms of SGLT2 inhibitors.","volume":"23","author":"Salvatore","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R34-20260831","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12933-023-01855-y","article-title":"Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review.","volume":"22","author":"Panico","year":"2023","journal-title":"Cardiovasc Diabetol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:01:23Z","timestamp":1788195683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":34,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049239","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"2026-01-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}